Key facts
- VentriJect’s last known valuation is $7.7M (Aug 2025).
- It has raised $4.8M; the latest was Later Stage VC ($2.0M) in Aug 2025.
- Notable investors include Plug and Play Tech Center, Denmark's Export and Investment Fund, AWRC Wellbeing Accelerator, Aalborg University, Carsten Stendevad — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for VentriJect
- ·The full record, as it builds
Funding rounds
No funding rounds for VentriJect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VentriJect
Developer of a medical device designed to measure maximal oxygen consumption. The company utilizes advanced seismocardiography to capture and analyze the mechanical vibrations generated by the beating heart and transmitted to the chest wall, enabling patients and users to measure cardiorespiratory fitness.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2018
- Employees
- 8
- Website
- ventriject.com/
- Ownership
- Privately Held (backing)
VentriJect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VentriJect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VentriJect in its N-PORT filings yet. We sweep new filings monthly.